Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
699 participants
OBSERVATIONAL
2006-03-31
2008-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation
NCT02134379
Physiological Response to Exercise: Sensor Evaluation at Specified Exertions
NCT01229137
Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial
NCT01570153
Cardiac Resynchronisation Study
NCT01213537
RECOVER-HF Pilot Study of SDS in Heart Failure
NCT05592392
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Algorithm Test Set
No interventions assigned to this group
2
Algorithm Development Set
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients prescribed to the LATITUDE(R) system configured for at least weekly device interrogations and symptoms reporting.
* Patients willing to use the LATITUDE(R) enabled weight scale.
Exclusion Criteria
* Patients that have received routinely scheduled intravenous inotropic therapy as part of their drug regimen within the past 90 days.
* Both
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gregory Ewald, M.D.
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
F. Roosevelt Gilliam, M.D.
Role: PRINCIPAL_INVESTIGATOR
Cardiology Associates of Northeast Arkansas
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DECODE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.